- India Pesticides Limited is fundamentally a maker of the pure chemical building blocks that go into crop-protection sprays and anti-fungal skin creams - it sells these to the world’s big agrochemical and pharmaceutical companies, and also sells formulations directly to farmers. Founded in 1984 in Lucknow and manufacturing since 1991, the company transformed itself in 2018 by starting to export herbicides from its new Sandila plant, shifting from a domestic player into a global supplier. The approach that explains everything else is a relentless drive to make complex, off-patent molecules in-house from the raw-material stage backwards, so it can be a lower-cost, non-Chinese alternative that global customers can depend on.
Business segments
A single integrated engine with two customer-facing streams - a technical-ingredients business that sells pure active chemicals to global formulators, and a branded-formulations business that sells finished crop-protection products to Indian farmers, both fed by the same manufacturing and R&D backbone.
1. Technicals and APIs: the pure-molecule factory for the world’s formulators
The company makes the active chemical ingredients that other companies turn into finished weed-killers, fungicides and anti-fungal drugs, and it wins by making molecules that few others can, often from raw materials it produces itself.
- Sells purity, not brands - it manufactures technical-grade active ingredients (Technicals) for pesticides and active pharmaceutical ingredients (APIs) for dermatological drugs, selling them on a per-unit basis to business customers who then formulate them into shelf-ready products.
- Sole-supplier status on several molecules - it is the only Indian manufacturer and a top global producer for the fungicides Captan and Folpet, and the sole Indian maker of a Thiocarbamate herbicide, which means customers have few alternatives and the company has pricing power. In mid-2025, India imposed a five-year anti-dumping duty on Chinese imports of Pretilachlor and its intermediate PEDA, further strengthening its domestic position.
- R&D turns lab recipes into factory processes - two in-house R&D centres with 25 scientists take molecules from gram-level experiments through a pilot plant to full commercial scale, developing new synthetic routes and cutting production costs by 2-5% through process re-engineering. The company also holds EU Technical Equivalence certifications for multiple products, which is the regulatory ticket needed to sell into Europe.
- Exports directly to formulators in over 35 countries - it does not use middlemen, selling straight to agrochemical companies in the US, UK, Europe, Japan and Australia, with exports making up about 39% of total revenue. It is also building a contract research and manufacturing (CRDMO) pipeline, scaling up compounds for partners from Japan, the US and Australia.
2. Branded formulations: the farmer-facing business built on its own molecules
The company takes the same technical ingredients it manufactures and sells them as finished, branded crop-protection products directly to Indian farmers through a network of over 5,000 dealers.
- Captures the full value chain - by formulating its own Technicals into end-use products like the herbicide Grip or the fungicide Dollar, it earns margin on both the ingredient and the finished product, and the formulations business has grown to 29% of revenue.
- Capacity added ahead of demand - total formulations capacity was scaled up to 10,000 tonnes per year in mid-2025, a jump from 6,500 tonnes, because the existing lines were already running at 95% utilisation.
- Export registrations are opening new doors - the company is securing product registrations for its branded formulations in markets like Serbia and Australia, laying the groundwork for an international branded business beyond its domestic stronghold.
3. Hamirpur facility: the next decade’s capacity under construction
A greenfield multi-product plant being built block-by-block through a wholly-owned subsidiary, designed to eventually add 30,000 tonnes of technicals capacity and house specialty products.
- A phased, pay-as-you-grow approach - the 25-acre site in Uttar Pradesh has central infrastructure for 10 production blocks already in place, with only 2 blocks operational as of early 2026, producing small volumes of Technicals and Formulations. Two more blocks are expected online in the next financial year, spreading the capital outlay over time.
- A separate legal entity with its own leadership - the facility is run by Shalvis Specialities Limited, a 100% subsidiary with its own CEO, and has already secured 29 product registrations from India’s Central Insecticides Board, giving it a regulatory head start.
Group structure and partners
The company operates through the parent and one active manufacturing subsidiary, with a promoter family that has stepped back from executive roles into governance, and a strategic partnership with a Japanese agrochemical major.
- Shalvis Specialities Limited is the 100% subsidiary incorporated in 2021 to expand manufacturing capacity for agrochemicals, intermediates and APIs.
- Amona Specialities Private Limited was a 51% subsidiary incorporated in 2024 to pursue an asset-light, registration-and-marketing model inspired by Sharda Cropchem, but the Company received an intimation from the subsidiary on March 30, 2025 that it had been decided to dissolve voluntarily.
- A three-year supply contract with a major Japanese agrochemical company, signed in early 2024, locks in demand for an intermediate and signals the company’s credibility as a long-term partner for multinationals.
- The founder, Anand Swarup Agarwal, stepped down as Chairman in late 2023 to make way for an independent Chairperson, while his two sons joined the Board as non-executive directors, separating family ownership from day-to-day management. The CEO, Dheeraj Kumar Jain, is a chemical engineer with over 50 years of industry experience and more than three decades at the company.